[Spironolactone as a relay for cyproterone acetate in hyperandrogenic women].

@article{Broux2020SpironolactoneAA,
  title={[Spironolactone as a relay for cyproterone acetate in hyperandrogenic women].},
  author={E. Broux and D. Dewailly and S. Catteau-Jonard},
  journal={Gynecologie, obstetrique, fertilite \& senologie},
  year={2020}
}
Objectives Cyproterone acetate is actually the first-line anti-androgenic treatment for severe hyperandrogenism in women. However, as this treatment is currently controversial, the objective of the study was to evaluate the safety and efficacy of spironolactone as a relay for cyproterone acetate. Methods This is a monocentric retrospective study conducted between December 2002 and January 2018 at the Jeanne de Flandre Hospital at the University Hospital Center of Lille. Patients with clinical… Expand